System and method of administering a pharmaceutical gas to a patient
Described are methods and systems for delivering a pharmaceutical gas to a patient. The methods and systems provide varying quantities of pharmaceutical gas delivered to the patient in two or more breaths based on the monitored respiratory rate or changes in the patient's respiratory rate.
1. A method of administering a pharmaceutical gas comprising nitric oxide to a patient, the method comprising:
delivering a first quantity of pharmaceutical gas comprising nitric oxide to the patient in a first breath;
determining whether the patient's respiratory rate increases or decreases; and
delivering a one or more of:
(i) a quantity of pharmaceutical gas in a subsequent breath that is greater than the first quantity in response to a decrease in the patient's respiratory rate; or
(ii) a quantity of pharmaceutical gas in a subsequent breath that is less than the first quantity in response to an increase in the patient's respiratory rate.
2. The method of claim 1 , wherein the pharmaceutical gas is delivered to the patient every breath.
3. The method of claim 1 , wherein one or more of the first quantity and the quantity delivered in the subsequent breath is delivered during the first half of inspiration.
4. The method of claim 1 , wherein varying the quantity of pharmaceutical gas delivered to the patient avoids high unsafe doses or doses too low to be effective.
5. A nitric oxide delivery system comprising:
an inlet to connect to a source of pharmaceutical gas comprising nitric oxide;
an outlet to connect to a device that introduces the pharmaceutical gas to a patient; and
a gas control system that delivers a varying quantity of pharmaceutical gas to the patient based on changes in the patient's respiratory rate, wherein one or more of:
(i) the quantity delivered in a subsequent breath is greater than the quantity delivered in a previous breath in response to a decrease in the patient's respiratory rate; or
(ii) the quantity delivered in a subsequent breath is less than the quantity delivered in a previous breath in response to an increase in the patient's respiratory rate.
6. The nitric oxide delivery system of claim 5 , further comprising a breath trigger sensor to measure the patient's respiratory rate.
7. The nitric oxide delivery system of claim 5 , wherein the gas control system delivers the quantity of pharmaceutical gas during the first half of the patient's inspiratory cycle.
8. The nitric oxide delivery system of claim 5 , wherein the gas control system delivers the pharmaceutical gas to the patient every breath.
9. The nitric oxide delivery system of claim 5 , wherein the device receives from a user one or more of: mass of drug; mass of drug per unit of time; moles of drug; moles of drug per unit of time; mass of drug per unit of ideal body weight per unit of time; mass of drug per unit of ideal body weight; moles of drug per unit of ideal body weight per unit of time; or moles of drug per unit of ideal body weight.
10. The nitric oxide delivery system of claim 5 , wherein the device receives from a user a mass of drug per unit of ideal body weight per unit of time.
11. The nitric oxide delivery system of claim 5 , wherein the device receives from a user one or more of: time duration of treatment; patient's ideal body weight; patient's height; or patient's sex.
12. A method of administering a pharmaceutical gas comprising nitric oxide to a patient, the method comprising:
receiving a desired quantity of nitric oxide to be delivered to the patient over a plurality of breaths;
delivering a first quantity of pharmaceutical gas comprising to the patient in a first breath;
monitoring the patient's respiratory rate or changes in the patient's respiratory rate; and
varying the quantity of pharmaceutical gas delivered to the patient in one or more subsequent breaths based on the monitored respiratory rate or changes in the patient's respiratory rate.
13. The method of claim 12 , wherein the quantity delivered in the subsequent breath is greater than the first quantity in response to a decrease in the patient's respiratory rate.
14. The method of claim 12 , wherein the quantity delivered in the subsequent breath is less than the first quantity in response to an increase in the patient's respiratory rate.
15. The method of claim 12 , wherein varying the quantity of pharmaceutical gas delivered to the patient avoids high unsafe doses or doses too low to be effective.
16. The method of claim 12 , wherein receiving a desired quantity of nitric oxide to be delivered to the patient comprises receiving one or more of: mass of drug per unit of time; moles of drug per unit of time; mass of drug per unit of ideal body weight per unit of time; or moles of drug per unit of ideal body weight per unit of time.
17. The method of claim 12 , wherein receiving a desired quantity of nitric oxide to be delivered to the patient comprises receiving a mass of drug per unit of ideal body weight per unit of time.
18. The method of claim 12 , further comprising receiving one or more of: time duration of treatment; patient's ideal body weight; patient's height; or patient's sex.
19. The method of claim 12 , wherein one or more of the first quantity and the quantity delivered in the subsequent breath is delivered during the first half of inspiration.
20. The method of claim 12 , wherein the pharmaceutical gas is delivered to the patient every breath.